Healthcare Distribution Alliance – Patients Move Us.
Share Print
News

News

FEATURED NEWS

Results: 30 Articles found.
  • HDA Statement on Senator McCaskill’s Opioid Report and the Role of Pharmaceutical Distributors in Addressing National Crisis
    July 12, 2018

    In response to a new report from Sen. Claire McCaskill (D-Mo.) regarding the role of distributors in addressing the country’s opioid abuse epidemic, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.

  • Fact Check: Where 60 Minutes Got it Wrong on the Opioid Crisis
    July 12, 2018

    Over the last year, 60 Minutes, in partnership with The Washington Post, has presented several misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid crisis, including the subsequent enforcement of The Ensuring Patient Access and Effective Drug Enforcement Act. To understand the country’s opioid epidemic and the solutions needed to reduce diversion and misuse of prescription opioids, we need to separate fact from fiction.

  • HDA Files Lawsuit to Block New York Opioid Law
    July 6, 2018

    Today, the Healthcare Distribution Alliance (HDA), the national trade association for pharmaceutical distributors, filed suit in the U.S. District Court for the Southern District of New York to block enforcement of New York’s Opioid Stewardship Act. The act imposes an unconstitutional $600 million punitive surcharge on pharmaceutical distributors and manufacturers. It bypasses judicial due process and impedes the industry’s comprehensive efforts to mitigate opioid abuse and misuse.

  • Verification Router Service Progress Update
    June 27, 2018

    As mentioned in our February 16 blog post, HDA and industry participants continue to make progress working with solution providers as Verification Router Service (VRS) solutions are developed for the 2019 DSCSA saleable returns requirement. This work has taken three paths: establishing governance processes; creating testing scenarios; and launching the testing phase.

  • Michael A. Conley of Novartis Pharmaceuticals Recognized with 2018 Nexus Award for Lifetime Achievement
    June 12, 2018

    The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael A. Conley of Novartis Pharmaceuticals Corporation with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the Roche Group, and Mylan Inc.

Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365